Qube Research & Technologies (QRT)
ICPT

Qube Research & Technologies (QRT)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-121,743
Closed -$1.64M – 3184
2023
Q1 		$1.64M Buy
121,743
+65,148
+115% +$1.13M 0.01% 1095
2022
Q4 		$700K Buy
+56,595
New +$801K ﹤0.01% 1356
2022
Q3 		– Sell
-16,174
Closed -$223K – 3192
2022
Q2 		$223K Buy
+16,174
New +$259K ﹤0.01% 1688

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ICPT Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 121,743 shares — an estimated $1.64M sold.

Qube Research & Technologies (QRT) first reported a position in ICPT in Q2 2022 and held it in 3 quarters. The position peaked at $1.64M in Q1 2023. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 121,743 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $1.64M.
  • Qube Research & Technologies (QRT) first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Intercept Pharmaceuticals, Inc. position peaked at $1.64M in Q1 2023.
  • 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.